Clinical and epidemiological characterization of patients with COVID-19

Authors

Keywords:

COVID‑19, epidemiology, COVID-19, SARS-CoV-2, elderly, COVID-19.

Abstract

Introduction: The SARS-CoV-2 virus is transmissible between humans and has caused a pandemic.
Objective: To characterize clinically and epidemiologically patients with COVID-19.
Methods: Descriptive study, between March and May 2020, of 187 patients confirmed for SARS-CoV-2, by the real-time polymerase chain reaction test. The variables described were: age, sex, comorbidities, state at discharge and admission to the intensive care ward, confirmation of the direct cause of death and fatality; in addition, correlations between these variables were explored.
Results: The female sex prevailed with 54.5% and the age group between 18 to 59 years (52.4%), the mean age was higher than 40 years. 91.9% of the patients were discharged alive and 88.4% did not require intensive care. The fatality was 6.9%. There was a statistically significant correlation between the state at the deceased discharge and the stay in intensive care, arterial hypertension, other comorbidities and being 60 years of age or older.
Conclusions: Patients with clinical symptoms and signs predominated, in whom admission to the ICU was not necessary, a higher incidence was observed in females and between 18 and 59 years for both sexes. All the deceased under the age of 60 were male. There was a strong correlation between the deceased discharge status, with the stay in intensive care, HBP, other comorbidities, and being 60 years old and over.

Downloads

Download data is not yet available.

References

1. Ge H, Wang X, Yuan X, Xiao G, Wang C, Deng T, Yuan Q, Xiao X. The epidemiology and clinical information about COVID-19. Eur J Clin Microbiol Infect Dis. 2020 [acceso: 20/05/2020]; 39(6):1011-1019. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154215/

2. Medeiros de Figueiredo A, Antonio Daponte A, Moreira Marculino de Figueiredo DC, Gil-García E, Kalache A. Letalidad del COVID-19: ausencia de patrón epidemiológico. Gaceta Sanitaria. 2020 [acceso: 20/05/2020]; 1855: [aprox. 13 p.]. Disponible en: https://www.gacetasanitaria.org/es-letalidad-del-covid-19-ausencia-patron-avance-S0213911120300844?newsletter=true&coronavirus

3. De Natale G, Ricciardi V, De Luca G, De Natale D, Di Meglio G, Ferragamo A, et al. The COVID-19 Infection in Italy: A Statistical Study of an Abnormally Severe Disease. J. Clin. Med. 2020 [acceso: 30/05/2020]; 9(5):15640. Disponible en: https://www.mdpi.com/2077-0383/9/5/1564/htm

4. Hernández Rodríguez J. Aspectos clínicos relacionados con el Síndrome Respiratorio Agudo Severo (SARS-CoV-2). Revista Habanera de Ciencias Médicas. 2020 [acceso: 20/05/2020]; 19(Supl): e3279[aprox. 18 p.]. Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/3279

5. Qiu H, Wu H, Hong L, Luo Y, Song Q, Chen D. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study. The Lancet Infectious Diseases. 2020[acceso: 30/05/2020]; 20(6):689-696. Disponible en: https://www.sciencedirect.com/science/article/pii/S1473309920301985

6. Calvo C, García López-Hortelano M, de Carlos Vicente JC, Vázquez Martínez JL. Grupo de trabajo de la Asociación Española de Pediatría para el brote de infección por Coronavirus, colaboradores con el Ministerio de Sanidad Recomendaciones sobre el manejo clínico de la infección por el «nuevo coronavirus» SARS-CoV2. An Pediatr (Barc). 2020 [acceso: 20/05/2020]; 92:241.e1-241.e11. Disponible en: https://www.sciencedirect.com/science/article/pii/S169540332030076X

7. Moreno-Martínez FL, Moreno López FL, Oroz Moreno R. Repercusión cardiovascular de la infección por el nuevo coronavirus SARS-CoV-2 (COVID-19). Cor Salud. 2020[acceso: 04/06/2020]; 12(1): 3-17. Disponible en: http://www.revcorsalud.sld.cu/index.php/cors/article/view/588/1112

8. Palacios Cruz M, Santos E, Velázquez Cervantes MA, León Juárez M. COVID-19, a world wide public health emergency. Revista Clínica Española. 2020 [acceso: 20/05/2020];221(1):55-61. Disponible en: https://www.sciencedirect.com/science/article/pii/S0014256520300928

9. Ludvigsson JF. Systematic review of COVID‐19 in children shows milder cases and a better prognosis than adults. Acta pediatrician. 2020[acceso: 20/05/2020];109(6): 1088-1095. Disponible en: https://onlinelibrary.wiley.com/doi/full/10.1111/apa.15270

10. Garg S, Kim L, Whitaker M, O'Halloran A, Cummings C, Holstein R, et al. Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 - COVID-NET, 14 States, March 1-30, 2020. MMWR Morb Mortal Wkly Rep. 2020[acceso: 02/06/2020]; 69:458-464. Disponible en: https://www.cdc.gov/mmwr/volumes/69/wr/mm6915e3.htm?s%20cid=-mm6915e3%20w

11. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020[acceso: 03/06/2020]; 395: 497-506. Disponible en: https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736%2820%2930183-5.pdf

12. Xie J, Tong Z, Guan X, Du B, Qiu H. Clinical characteristics of patients who died of coronavirus disease 2019 in China. JAMA Netw Open. 2020 Mar [acceso: 31/05/2020]; 3(4);[aprox. 6 p.]. Disponible en: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2764293

13. Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020 Mar 26 [acceso: 24/05/2020]; 3(4):[aprox. 7 p.]. Disponible en: https://www.researchgate.net/publication/340222738_Clinical_charact-eristics_of_113_deceased_patients_with_coronavirus_disease_2019_-retrospective_study

14. Trilla A. One world, one health: The novel coronavirus COVID-19 epidemic. Med Clin (Barc). 2020 Mar 13[acceso: 20/05/2020]; 154(5):175-177. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094554/

15. Lithander FE, Neumann S, Tenison E, Lloyd K, Welsh TJ, Rodrigues JCL, et al. COVID-19 in Older People: A Rapid Clinical Review. Age and Ageing. 2020 May 6[acceso: 11/06/2020]; 49(4):501-15. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239238/pdf/afaa093.pdf

16. Bermejo Martin J F, Almansa R, Torres A, González Rivera M, Kelvin DJ. COVID-19 as a cardiovascular disease: the potential role of chronic endothelial dysfunction. Cardiovascular Research. 2020 [acceso: 10/06/2020]; 116(10):e132-e133 cvaa140. Disponible en: https://academic.oup.com/cardiovascres/advance-article/doi/10.1093/cvr/cvaa140/5838569

Downloads

Published

2021-02-04

How to Cite

1.
Diaz Morales Y, Tejeda Castañeda E, Díaz Padrón EG, Santiago Lopez W, Oyarzabal Guerra A, Calderón Medina NA. Clinical and epidemiological characterization of patients with COVID-19. Rev Cubana Med Milit [Internet]. 2021 Feb. 4 [cited 2025 Mar. 13];50(1):e0210815. Available from: https://revmedmilitar.sld.cu/index.php/mil/article/view/815

Issue

Vol. 50 No. 1 (2021): January - March

Section

Research Article

License

Authors who have publications with this Journal accept the following terms:

  • The authors will retain their copyright and guarantee the Journal the right of first publication of their work, which will simultaneously be subject to the Creative Commons Attribution License. The content presented here can be shared, copied and redistributed in any medium or format; Can be adapted, remixed, transformed or created from the material, using the following terms: Attribution (giving appropriate credit to the work, providing a link to the license, and indicating if changes have been made); non-commercial (you cannot use the material for commercial purposes) and share-alike (if you remix, transform or create new material from this work, you can distribute your contribution as long as you use the same license as the original work).
  • The authors may adopt other non-exclusive license agreements for the distribution of the published version of the work (for example: depositing it in an institutional electronic archive or publishing it in a monographic volume) as long as the initial publication in this Journal is indicated.
  • Authors are allowed and recommended to disseminate their work through the Internet (e.g., in institutional electronic archives or on their website) before and during the submission process, which can produce interesting exchanges and increase citations. of the published work.